Study of cell proteins with growth factors for knee arthritis
Part of Bones, joints & muscles, Injuries & trauma clinical trials.
This trial tests a treatment made from stem cell proteins combined with growth factors from your own blood. It is injected into the knee to help repair cartilage and reduce pain in people with mild to moderate knee osteoarthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must have osteoarthritis diagnosed by a doctor in one or both knees
- Must have mild to moderate arthritis (grade I or II)
- Must have knee pain of at least 20 mm on a pain scale
- Must be between 30 and 55 years old
- Must have a body mass index (BMI) around 27, give or take a few points
- Must not have had any knee surgery in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This trial compares a new treatment called secretome (from stem cells) to a standard gel injection (sodium hyaluronate) for knee arthritis. It aims to see if secretome can better reduce pain and improve function.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This study tests a treatment made from your own body's healing components to reduce knee pain. It may help people with mild to moderate knee osteoarthritis who haven't had knee surgery or strong pain relievers lately.
This study tests whether an injection of stem cells (special cells that can help repair tissue) works better than a standard hyaluronic acid injection for knee osteoarthritis pain. Both treatments are injected into the knee to reduce pain and improve function.
This trial tests whether a new stem cell treatment, given during a surgical procedure, can help repair damaged cartilage in the knee. It is for people with moderate to severe knee pain and a specific size of cartilage injury.
Hear when a new Osteoarthritis (OA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.